Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Compumedics Limited ( (AU:CMP) ).
Compumedics Limited has released its 2025 Annual Report, highlighting its strategic growth platforms and core products in the sleep and neuroscience sectors. The report outlines the company’s ongoing commitment to innovation and market expansion, which is expected to enhance its industry positioning and provide significant value to stakeholders.
The most recent analyst rating on (AU:CMP) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Compumedics Limited stock, see the AU:CMP Stock Forecast page.
More about Compumedics Limited
Compumedics Limited operates in the medical technology industry, focusing on the development and commercialization of products related to sleep diagnostics and neuroscience. The company is known for its innovative solutions in these areas, catering to a global market with a strong emphasis on advancing healthcare technologies.
Average Trading Volume: 112,166
Technical Sentiment Signal: Sell
Current Market Cap: A$54.78M
Find detailed analytics on CMP stock on TipRanks’ Stock Analysis page.